Insulin Glargine (U-100) Cartridge Systems and Pens and Xopenex HFA
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Xopenex HFA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Xopenex Inhalation Solution Concentrate
- Insulin Glargine (U-100) Cartridge Systems and Pens-Xopenex Pediatric
- Insulin Glargine (U-100) Cartridge Systems and Pens-Xospata
- Insulin Glargine (U-100) Cartridge Systems and Pens-Xoten-C
- Insulin Glargine (U-100) Cartridge Systems and Pens-Xpect-AT
- Insulin Glargine (U-100) Cartridge Systems and Pens-Xpect-PE
- Xopenex HFA-Insulin Glargine (U-100) Vials
- Xopenex HFA-Insulin Glargine (U-300) Pens
- Xopenex HFA-Insulin glargine and lixisenatide
- Xopenex HFA-Insulin glargine and lixisenatide Subcutaneous
- Xopenex HFA-Insulin glargine, recombinant Subcutaneous
- Xopenex HFA-Insulin glulisine